“…This dichotomy is highlighted in reports of E2 treatment on cognition in post-menopausal women, with some reporting negative effects (Espeland et al, 2004; Mulnard et al, 2000; Rapp et al, 2003; Resnick et al, 2006; Shumaker et al, 2003) and others reporting benefits (Baker et al, 2012; Duff and Hampson, 2000; Maki et al, 2001; Miller et al, 2002; Smith et al, 2001; Wolf and Kirschbaum, 2002; Wolf et al, 1999), which receive support from basic science reports of estrogenic fortification of the central nervous system (Brinton et al, 2000; Chen et al, 2006; Hosoda et al, 2001; Pike, 1999). To reconcile these mixed reports, Brinton (2005) proposed a healthy cell bias of estrogen action, stating that E2 would be advantageous to a population of healthy cells, but detrimental to a population of declining or already injured cells.…”